Location: Home
  • search
  • go
  • Relate News
  • 8/26/2024CDE Solicits Public Comments on the Q&As on Clinical Guidelines for Dr...
  • 8/26/2024China Issues the Notice on Facilitating the BMI for Urban and Rural Re...
  • 8/26/2024Chinese Pharma Cos Set Sights on Dominating Therapeutic Cancer Vaccine...
  • 8/26/2024Chinese and U.S. Scientists Unveil New AI Model to Advance Drug Disco...
  • 8/26/2024Recent Study Reveals Alarming Rise in Obesity-Related Cancers in China
  • 8/26/2024China Escalates Crackdown on Medical Insurance Frauds
  • 8/26/2024Over 70% of Village Clinics Now Covered by the BMI System
  • 8/23/2024China Approves Innovent's Dupert for Advanced Lung Cancer Treatment
  • 8/23/2024Recent Executive Moves
  • 8/22/2024Everest Medicines Announces Initiation of Clinical Trial for Personali...
  • 8/22/2024Jacobio Terminates Clinical Development of JAB-3068
  • 8/22/2024CDE Solicits Public Comments on the Guidelines for Clinical Virologica...
  • 8/22/2024Bridge Biothera Teams Up with HitGen to Develop Novel Cancer Drug
  • 8/22/2024China Further Opens Telecom, Education, and Healthcare Sectors to Fore...
  • 8/22/2024InnoCare Pharma: A Sample of Accelerated Commercialization for Biotech...
  • 8/22/2024What Drives China's Healthcare Expenditure? A Theoretical and Empirica...
  • 8/21/2024GenFleet Wins Chinese Approval of Its KRAS G12C Inhibitor
  • 8/21/2024Astellas Executive Indicted in China after Detention
  • 8/21/2024Six Drug Cos Sanctioned for Bid-Rigging in China’s Centralized Drug P...
  • 8/20/2024Merck Adjusts ADC Partnership with Kelun-Biotech, Takes Up One Option ...
  • 8/20/2024Adcendo Enters $1B Biobuck Deal for Multitude's Anti-TF ADC
  • 8/20/2024TYK Medicines Raises $74M thru IPO to Fund Core Asset Development
  • 8/20/2024U.S. Lawmakers Call on the FDA to Investigate Clinical Trials Conducte...
  • 8/20/2024AstraZeneca Gains Chinese Approval of New Asthma Drug
  • 8/20/2024Taking Stock of U.S.-China Biotechnology Competition (Asia Society)
  • 8/19/2024Astellas Secures Chinese Approval of Nectin-4 ADC Drug
  • 8/19/2024NMPA Restores Import, Sales and Use of UCB's Keppra
  • 8/19/2024Germany Warns of Potential Drug Shortages Due to China's Espionage Law
  • 8/19/2024Aurobindo to Begin Production in China Soon
  • 8/19/2024FDA Lifts Partial Hold on BioNTech-MediLink ADC Study
  • Page:52/774 Total number of articles:23207: [First][<<] [50] [51] [52] [53] [54] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group